Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
出版年份 2020 全文链接
标题
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
作者
关键词
-
出版物
Cancers
Volume 12, Issue 10, Pages 2948
出版商
MDPI AG
发表日期
2020-10-16
DOI
10.3390/cancers12102948
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
- (2019) Raffit Hassan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrative Molecular Characterization of Malignant Pleural Mesothelioma
- (2018) Julija Hmeljak et al. Cancer Discovery
- Consensus Report of the 2015 Weinman International Conference on Mesothelioma
- (2016) Michele Carbone et al. Journal of Thoracic Oncology
- The Genetic Landscape of Malignant Pleural Mesothelioma: Results from Massively Parallel Sequencing
- (2016) Marieke Hylebos et al. Journal of Thoracic Oncology
- The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification
- (2016) Francoise Galateau-Salle et al. Journal of Thoracic Oncology
- Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations
- (2016) Raphael Bueno et al. NATURE GENETICS
- Matrix-remodeling associated 5 as a novel tissue biomarker predicts poor prognosis in non-small cell lung cancers
- (2015) Yi He et al. Cancer Biomarkers
- BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma
- (2015) Hakan Alakus et al. Journal of Translational Medicine
- Expression status of candidate genes in mesothelioma tissues and cell lines
- (2015) Ombretta Melaiu et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
- (2015) Noemi Andor et al. NATURE MEDICINE
- Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing
- (2015) Brandon S. Sheffield et al. PLoS One
- Pharmacogenetics of pemetrexed combination therapy in lung cancer: pathway analysis reveals novel toxicity associations
- (2014) A Corrigan et al. PHARMACOGENOMICS JOURNAL
- Molecular pathogenesis of malignant mesothelioma
- (2013) Y. Sekido CARCINOGENESIS
- Asbestos is not just asbestos: an unrecognised health hazard
- (2013) Francine Baumann et al. LANCET ONCOLOGY
- Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma
- (2013) Pascal Andujar et al. MUTAGENESIS
- Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma
- (2012) Yoshie Yoshikawa et al. CANCER SCIENCE
- Loss of the Tumor Suppressor BAP1 Causes Myeloid Transformation
- (2012) A. Dey et al. SCIENCE
- A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma
- (2011) Ombretta Melaiu et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- (2011) Matthew Bott et al. NATURE GENETICS
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Malignant pleural mesothelioma: Genome-wide expression patterns reflecting general resistance mechanisms and a proposal of novel targets
- (2009) Oluf Dimitri Røe et al. LUNG CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More